Consolidated Statements of Cash Flows (USD $) In Thousands, unless otherwise specified	12 Months Ended
	Jun. 29, 2013	Jun. 30, 2012	Jun. 25, 2011
Cash flows from operating activities:
Net income	$ 454,912	$ 386,727	$ 489,009
Adjustments to reconcile net income to net cash provided by operating activities:
Stock-based compensation	83,808	89,867	94,297
Depreciation and amortization	207,136	211,096	205,062
Deferred taxes	25,372	30,759	140,084
In process research & development	2,800	1,600	0
Loss from sale of property, plant and equipment	(1,156)	(7,648)	12,946
Loss (gain) from sale of equity investments	0	(1,811)	0
Other Noncash Expense	4,621	1,670	0
Tax benefit (shortfall) related to stock-based compensation	8,197	3,112	30,546
Excess tax benefit related to stock-based compensation	(18,923)	(17,482)	(12,869)
Net of Asset Impairment Charges	24,929	30,645	0
Cash Provided by (Used in) Operating Activities, Discontinued Operations	(3,285)	(45,372)	0
Changes in assets and liabilities:
Accounts receivable	32,023	(19,262)	43,256
Inventories	(35,245)	(432)	(29,435)
Other current assets	(20,533)	(16,757)	53,255
Accounts payable	(32,510)	25,515	(4,746)
Income taxes payable	70,156	134,967	(45,318)
Deferred income on shipments to distributors	277	(10,601)	11,102
Accrued liabilities - litigation settlement	0	0	(173,000)
All other accrued liabilities	15,356	(39,871)	47,265
Net cash provided by operating activities	817,935	756,722	861,454
Cash flows from investing activities:
Purchases of property, plant and equipment	(216,672)	(264,348)	(175,253)
Proceeds from sale of property, plant, and equipment	19,196	16,883	27,624
Proceeds from Collection of Notes Receivable	10,786	0	0
Acquisitions	(2,767)	(168,544)	(80,918)
Cash Provided by (Used in) Investing Activities, Discontinued Operations	0	56,607	0
Purchases of available-for-sale securities	0	(25,108)	(49,787)
Payments to Acquire Investments	(500)	(3,480)	0
Proceeds from Divestiture of Businesses	585	3,225	0
Proceeds from sales/maturities of available-for-sale securities	50,000	0	0
Net cash used in investing activities	(139,372)	(384,765)	(278,334)
Cash flows from financing activities
Excess tax benefit from stock-based compensation plans	18,923	17,482	12,869
Mortgage liability	0	0	(3,237)
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability	(13,781)	0	0
Repayment of notes payable	(303,500)	(20,806)	(1,422)
Long-term debt, net of issuance costs	494,395	0	0
Payments of Debt Issuance Costs	(3,921)	0	0
Proceeds from Issuance of Common Stock	(29,042)	(29,649)	(28,839)
Proceeds from Stock Options Exercised	71,342	49,906	24,845
Proceeds from Issuance of Shares under Incentive and Share-based Compensation Plans, Including Stock Options	36,297	33,772	28,850
Repurchase of common stock	(375,135)	(246,412)	(231,012)
Dividends paid	(280,215)	(257,731)	(249,145)
Net cash used in financing activities	(384,637)	(453,438)	(447,091)
Net increase (decrease) in cash and cash equivalents	293,926	(81,481)	136,029
Cash and cash equivalents:
Beginning of year	881,060	962,541	826,512
End of year	1,174,986	881,060	962,541
Supplemental disclosures of cash flow information:
Cash (refunded) paid, net during the year for income taxes	19,080	39,827	(15,529)
Cash paid for interest	10,624	10,890	10,264
Noncash financing and investing activities:
Accounts payable related to property, plant and equipment purchases	16,825	26,079	22,841
Notes Assumed	$ 4,504	$ 0	$ 0